Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.98 USD | +4.86% | +6.36% | -28.31% |
01:15am | Transcript : Immunocore Holdings plc - Shareholder/Analyst Call | |
May. 29 | Immunocore Converts Skin Cancer Therapy Phase 2/3 Trial to Phase 3 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.31% | 2.45B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- IMCR Stock
- News Immunocore Holdings plc
- Transcript : Immunocore Holdings plc Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-14-2023 01